HOWL
Werewolf Therapeutics Inc
NASDAQ: HOWL · HEALTHCARE · BIOTECHNOLOGY
$0.68
-8.11% today
Updated 2026-04-29
Market cap
$33.05M
P/E ratio
—
P/S ratio
10.21x
EPS (TTM)
$-1.33
Dividend yield
—
52W range
$1 – $2
Volume
0.4M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$7.00
+929.41%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-11.02M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $16.40M | $19.94M | $1.89M | $0.00 | $0.00 |
| Net income | $-51.56M | $-37.37M | $-70.52M | $-60.82M | $-8.38M |
| EPS | — | — | — | — | $-1.33 |
| Free cash flow | $-44.21M | $-33.38M | $-56.44M | $-60.29M | $-11.02M |
| Profit margin | -314.40% | -187.37% | -3,740.85% | — | — |
Peer comparison
Smart narrative
Werewolf Therapeutics Inc trades at $0.68. Our Smart Value Score of 24/100 indicates the stock is weak.
Frequently asked questions
What is Werewolf Therapeutics Inc's stock price?
Werewolf Therapeutics Inc (HOWL) trades at $0.68.
Is Werewolf Therapeutics Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Werewolf Therapeutics Inc (HOWL)?
The analyst target price is $7.00, representing +929.4% upside from the current price of $0.68.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio10.21x
ROE-123.90%
Beta0.54
50D MA$0.80
200D MA$1.08
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—